Allogene Therapeutics, Inc. (ALLO)

2.08 +0.03 (+1.46%) USD  |  NASDAQ  |  Feb 23, 16:00
2.10 +0.02 (+0.96%) After-Hours: 19:59
More

Allogene Therapeutics Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for ALLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
LadRx Corp. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade